Marty Schenker

Senior Counsel

I focus on high-stakes disputes, and have delivered wins to clients in many multi-billion dollar and bet-the-company cases.

Martin Schenker focuses on complex business litigation. He has a proven track record of successful trial and arbitration results in bet-the-company cases for a broad group of clients, including companies in the technology, life sciences and utility industries. Marty, who holds a graduate degree in economics, has extensive experience litigating complex economic and financial matters.

Download full bio 


  • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 

  • Cooley Successfully Represents PG&E in One of the Most Complex Bankruptcy Confirmation Proceedings in History 

  • Medivation Agrees to Sell to Pfizer for $14 Billion 

  • Cooley Successfully Resolves Qualcomm’s Global Licensing Dispute with Nokia through Multi-Billion Dollar Deal 

  • Complete win for Gilead Sciences in dispute involving breakthrough SOVALDI treatment  

  • View all


  • Harvard Law School
    JD, magna cum laude, 1983

  • London School of Economics and Political Science
    MS, Economics

  • University of California, Davis
    BA, highest honors, Phi Beta Kappa, 1978

Admissions & Credentials



  • American Bar Association

  • The Bar Association of San Francisco

Rankings & Accolades

    Lawyers' Committee for Civil Rights Father Cuchulain Moriarty Award (2021)

    American Lawyer: Global Dispute of the Year – Commercial Arbitration (2015)

    Northern California Super Lawyers (2006-2016)

    Financial Times: Innovative Lawyers